Highlights
1 patent
About
Medical Cannabis Analytics
Cannasoul is an Israeli cannabis drug-discovery company developing therapeutics derived from natural compounds. Cannasoul's proprietary analytical platform, data-driven approach, knowhow, and clinical trial framework support active compound identification and development, from botanical extract through clinical approved formulation. Cannasoul has analyzed over 100 cannabinoids and 100 terpenes. The company's subsidiaries include MyPlant Bio, Psyga Bio, Nidra Logic, and CaVnox.
Identity
| Name | Cannasoul Analytics |
|---|---|
| Slug | cannasoul |
| Former names | Cannsoul Analytics |
| Type / kind | startup |
| Crunchbase ID | cannasoul-analytics |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkLiKzNgKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Caesarea |
| HQ address | Tarshish St 5, Caesarea, Israel |
Web & social
| Website | https://cannasoul.co.il/ |
|---|---|
| https://www.linkedin.com/company/35711926 | |
| YouTube | https://www.youtube.com/channel/UCskPyUr2YPkd4QsNzXWhBrQ |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesHealthcareLaboratories
Business models
B2B
Tags
pharmaceuticalsmedical-cannabisclinical-trialsdrug-discoverybiotechnologytherapeuticscannabis
Funding
| Total raised | $4.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}